Literature DB >> 8761241

Ecstasy and neurodegeneration. ...such as ketamine.

D Shewan, P Dalgarno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8761241      PMCID： PMC2351801          DOI： 10.1136/bmj.313.7054.424

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Ecstasy and neurodegeneration.

Authors:  A R Green; G M Goodwin
Journal:  BMJ       Date:  1996-06-15

2.  Illicit use of ketamine in Scotland.

Authors:  P J Dalgarno; D Shewan
Journal:  J Psychoactive Drugs       Date:  1996 Apr-Jun

Review 3.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530
  3 in total
  2 in total

1.  Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line.

Authors:  Yoshimitsu Toyama; Hidesuke Shimizu; Yuji Suzuki; Yuichi Miyakoshi; Hayato Yoshioka
Journal:  Environ Health Prev Med       Date:  2006-05       Impact factor: 3.674

2.  Evaluation of inhibitory effect of recreational drugs on dopaminergic terminal neuron by PET and whole-body autoradiography.

Authors:  Skye Hsin-Hsien Yeh; Ming-Hsien Lin; Fan-Lin Kong; Chi-Wei Chang; Li-Chung Hwang; Chien-Feng Lin; Jeng-Jong Hwang; Ren-Shyan Liu
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.